AI Summary
5 min readWhy Your Brain Thinks You're Full (Even When You're Not)
Your bloodstream holds only about four grams of sugar at any moment—roughly a teaspoon. That narrow window is all your body has to work with, and it fights constantly to keep you there. Eat a massive dessert, and your body scrambles to store the excess. Starve yourself, and it scrambles to release reserves. The entire system is an incredibly precise balancing act, and the drugs now reshaping obesity treatment—semaglutide, Wegovy, Mounjaro—work by hijacking the same ancient hormonal signals that keep that balance intact.
The Two Hormones That Keep the Balance
Two main hormones from the pancreas manage blood sugar. Insulin is released when blood sugar is too high. It works by unlocking "doors" on muscle and fat cells—specific protein gates that normally stay closed—allowing glucose to enter and be stored. Without insulin, glucose can be standing right outside a cell, unable to get in. That is exactly what happens in type 1 diabetes: the blood is full of sugar, but the cells are starving.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of The Rest Is Science
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:00) **The Sweetness of Your Blood** - Michael and Hannah open with a surprising fact: there are only about four grams of sugar (a teaspoon) in your entire bloodstream at any moment.
- 2 (05:05) **The Two Master Hormones: Insulin and Glucagon** - Hannah explains the basic insulin-glucagon feedback loop that keeps blood sugar stable.
- 3 (08:55) **The Strange Clue: Oral vs. Injected Glucose** - Scientists noticed that drinking sugar triggers far more insulin than injecting the same amount directly into a vein.
- 4 (10:28) **The Ulcer Surgery Clue** - In the 1980s, patients who had part of their stomach removed to treat ulcers developed severe low blood sugar attacks.
- 5 (14:25) **The Anglerfish and the Discovery of GLP-1** - Scientists hunting for the glucagon gene in anglerfish found it also produces two mystery peptides, named GLP-1 and GLP-2.
- 6 (17:10) **Why GLP-1 Was a Breakthrough for Diabetes** - GLP-1's conditional action made it a far safer treatment than insulin for type 2 diabetes.
- 7 (19:04) **The Gila Monster to the Rescue** - The key to a long-lasting GLP-1 drug came from the venom of the Gila monster, a lizard that eats only five times a year.
+ Full timestamped outline available in the app
Show Notes
How did the Gila monster, a desert lizard that eats just five times a year, help unlock the science behind Ozempic, Wegovy and Mounjaro?
In this episode of The Rest Is Science, Professor Hannah Fry and Michael Stevens (Vsauce) trace the strange journey from a molecule found in lizard venom to medicines reshaping diabetes and weight-loss treatment, exploring how GLP-1 helps regulate blood sugar, appetite and the hum of ‘food noise’.
Early evidence suggests their effects may extend far beyond food, quieting cravings for alcohol and cigarettes, and even the urge to gamble.
What might this reveal about the biology of wanting itself, and how much control do any of us really have over what we crave?
-------------------
For more information about Cancer Research UK, their research, breakthroughs and how you can support them, visit https://www.cancerresearchuk.org/our-research/rest-is-science
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.
-------------------
Find The Rest Is Science all over the internet by clicking here.
-------------------
Video Producer: Adam Thornton + Teo Ayodeji-Ansell + Jack Meek
Animator: Sam Benson
Video & Social: Bex Tyrrell
Assistant Producer: Lucy Lipscombe
Producer: Simona Rata
Senior Producer: Lauren Armstrong-Carter
Chief Digital Officer: Samuel Oakley
Exec Producer: Neil Fearn
Learn more about your ad choices. Visit podcastchoices.com/adchoices
More from this podcast
The Rest Is Science →